Cesca Therapeutics (NASDAQ:KOOL) was down 41.9% during trading on Wednesday . The company traded as low as $0.76 and last traded at $0.54. Approximately 23,821 shares were traded during trading, a decline of 82% from the average daily volume of 129,766 shares. The stock had previously closed at $0.93.
Separately, ValuEngine upgraded Cesca Therapeutics from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd.
The company has a current ratio of 1.61, a quick ratio of 1.23 and a debt-to-equity ratio of 0.23.
Cesca Therapeutics (NASDAQ:KOOL) last announced its earnings results on Thursday, March 22nd. The biotechnology company reported $0.01 EPS for the quarter. The firm had revenue of $2.94 million for the quarter. Cesca Therapeutics had a negative return on equity of 20.31% and a negative net margin of 56.21%.
About Cesca Therapeutics
Cesca Therapeutics Inc develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the United States, China, rest of Asia, Europe, and internationally. The company develops automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products.
Receive News & Ratings for Cesca Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cesca Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.